SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp is experiencing extreme volatility and a potential short squeeze, driven by escalating geopolitical tensions threatening global oil supply, while investors are actively debating the impact of a recent share offering.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is a major topic as investors anticipate explosive earnings driven by insatiable AI demand for its high-bandwidth memory, with recent analyst upgrades reflecting a perceived "seller's market." Community discussion highlights a potential competitive edge for Micron amidst geopolitical tensions impacting South Korean memory chip rivals.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid widespread discussion and highly polarized views surrounding recent U.S. military actions in Iran, with many in the community debating if the moves are a strategic necessity or a political diversion from other issues like the Epstein files, causing concerns about escalating global conflicts and economic impacts.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is trending following a beat on revenue and a robust outlook, sparking community debate over its high valuation versus its leadership in securing rapidly expanding AI deployments, which the CEO emphasizes as a major growth opportunity for the cybersecurity firm.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is highly volatile amidst escalating Middle East tensions, fueled by reports of attacks on US assets and military responses. Community sentiment is sharply divided between those predicting a broader market correction and others aggressively buying dips, with discussions focusing on potential oil market disruption and wider global instability.

Texxon Holding Ltd. provides supply chain management services in East China. Its services include the sale of plastic, chemical raw materials, and other plastic raw materials. Its products are used in fabrics, coastings, resins, beverage packing, other downstream products, pipelines and pipes used in infrastructure, daily or food grade packing and agriculture membranes. The company was founded on January 20, 2022 and is headquartered in Shanghai, China.

Texxon Holding Ltd

Texxon Holding Ltd (NPT), a low-float Chinese stock, is trending with extreme volatility and massive volume driven by its recent IPO and subsequent over-allotment option exercise. The community is buzzing about significant price spikes and frequent trading halts, with many speculating on further gains while others voice concerns about its "pump and dump" characteristics.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as the market grapples with escalating Middle East tensions and US military actions to secure shipping in the Strait of Hormuz. The community is sharply divided, with many expressing frustration over consistent "V-shaped" rallies and perceived market manipulation, while others highlight the tech-heavy index's remarkable resilience to geopolitical uncertainty.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending due to significant volatility, initially sparked by reports of its inclusion on a U.S. Pentagon list of military-linked firmsa designation swiftly withdrawn and widely perceived by the community as manipulative 'fake news.' Compounding investor sentiment is the ongoing uncertainty surrounding its earnings release date, while discussions also highlight Alibaba's latest advancements in AI, particularly with its upgraded Qwen 3.5 model and robotics AI initiatives.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea Ltd. is trending following its Q4 earnings report, which showed robust revenue growth and optimistic Shopee GMV guidance, but was overshadowed by an EPS miss and increasing credit loss provisions. The community is actively debating whether the ensuing sharp sell-off is an overreaction to short-term pressures or a valid concern given rising competition and profitability challenges in its diverse e-commerce and digital finance segments.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is generating significant discussion following its Q4 earnings, where a wider-than-expected loss and high burn rate clash with the monumental achievement of 100% FAA Means of Compliance for its Midnight aircraft. Bulls view this as a critical de-risking milestone for its 2026 passenger flight target and highlight strong liquidity, while bears emphasize ongoing financial concerns, high expenses, and potential dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SELLAS Life Sciences Group (NASDAQ:SLS) Hits New 12-Month High - Time to Buy?

SELLAS Life Sciences Group (NASDAQ:SLS) Sets New 1-Year High - Here's What Happened...

<ul class="summary-bullets"><li>The ongoing GPS trial is an overall survival study and final analysis is expected once 80 deaths have occurred.</li><li>As of Dec. 26, 72 deaths have occurred, the company said earlier, highlighting that it had previously expected 80 patient deaths to occur by December end.</li><li>Maxim analyst Jason McCarthy previously noted that delays in an event-driven trial like SELLAS’ could be suggestive of extended survival benefit from GPS.</li></ul>Shares of Sellas Life Sciences (SLS) garnered the spotlight on Stocktwits on Friday as retail traders contemplated the company’s upcoming results from its late-stage trial for Galinpepimut-S (GPS). &nbsp;SELLAS is currently evaluating Galinpepimut-S (GPS) as a potential maintenance therapy in patients with Acute Myeloid Leukemia who have achieved complete remission following second-line salvage therapy.AML is a fast-growing cancer of the blood and bone marrow where immature white blood cells build up, crowding out healthy cells, leading to fatigue, infections, and bleeding.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>A Stocktwits user expressed optimism for data from the trial spurring a rally. “Till then it’s the accumulation game,” he said.<stembedurl>https://www.stocktwits.com/Heypentaco/message/646154506</stembedurl>Another opined that the GPS will be worth over $180/share to big pharma companies looking to buy Sellas.<stembedurl>https://www.stocktwits.com/67X_ROI_Q1_2026/message/646149937</stembedurl>Another user opined that now is the time to buy more shares of the company.<stembedurl>https://www.stocktwits.com/Polsky/message/646158337</stembedurl>Overall, retail sentiment around SLS stock stayed within the ‘extremely bullish’ territory over the past 24 hours, while message volume remained at ‘high’ levels. According to Stocktwits data, retail chatter around the stock has increased by about 453% over the past 90 days.<h2 class="st-heading-2">The GPS Trial</h2>The ongoing GPS trial is an overall survival study and final analysis is expected once 80 deaths have occurred. As of Dec. 26, 72 deaths have occurred, the company said earlier, highlighting that it had previously expected 80 patient deaths to occur by December end.“While the 80th event has not yet occurred, and we remain fully blinded, every passing month may increase the probability of a successful study as highlighted by key opinion leaders in our recent R&amp;D event. Conclusive data will follow the unblinding and analyses of the study results,” SELLAS CEO Angelos Stergiou then said.Maxim analyst Jason McCarthy then noted that delays in an event-driven trial like SELLAS’ could be suggestive of extended survival benefit from GPS.According to data from Koyfin, all three of the analysts covering SELLAS rate it ‘Buy’ or higher. The stock has an average price target of $6.83, hinting at further potential upside.<a href="https://stocktwits.com/symbol/SLS">SLS shares</a> have more than quadrupled over the past 12 months.Read More: <a href="https://stocktwits.com/news-articles/markets/equity/why-are-us-bank-stocks-seeing-heavy-selloffs-today/cZTcHyHRITv">Why Are US Banks Seeing Heavy Selloffs Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

SLS Stokes Retail Anticipation For Breakout Rally — What’s Driving The Interest?

SELLAS is currently evaluating Galinpepimut-S (GPS) as a potential maintenance therapy in patients with Acute Myeloid Leukemia who have achieved complete remission following second-line salvage therapy.

Equity

SELLAS is currently evaluating Galinpepimut-S (GPS) as a potential maintenance therapy in patients with Acute Myeloid Leukemia who have achieved complete remission following second-line salvage therapy.


<ul class="summary-bullets"><li>Sellas’ CEO referenced the company’s Phase 3 REGAL trial in a LinkedIn post, following its December update that the final analysis was approaching for GPS as a therapy in AML.</li><li>Anson Funds Management recently disclosed that it held a 4.9% stake in Sellas.</li><li>Last month, Sellas partnered with IMPACT-AML to advance AML treatments.</li></ul>Sellas Life Sciences Group Inc. (SLS) generated significant retail buzz on Monday as the stock shot up more than 15% to its highest levels in more than a month.According to Stocktwits data, message volume on the platform increased nearly 170% over the past 24 hours.<h2 class="st-heading-2">Retail Bullish On Potential Phase 3 REGAL Trial Results</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/SLS">SLS</a> on Stocktwits remained in the ‘bullish’ territory over the past 24 hours, amid ‘high’ message volumes.<img src="https://news.stocktwits-cdn.com/Sellas_jpg_9c62bbaf10.webp" alt="Sellas.jpg">On Sunday, Angelos M. Stergiou, President and CEO of Sellas, made a reference to the company’s Phase 3 REGAL trial in a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.linkedin.com/feed/update/urn:li:activity:7431478609229438976/">post</a> on LinkedIn. Last December, the company <a href="https://stocktwits.com/news-articles/markets/equity/sellas-life-sciences-group-stock-soars-as-it-nears-final-analysis-in-cancer-study/cL7dROARExt">said</a> it was nearing the final analysis from its Phase 3 REGAL trial for Galinpepimut-S (GPS) as a potential maintenance therapy in Acute Myeloid Leukemia (AML).AML is a fast-growing blood and bone marrow cancer in which abnormal white blood cells crowd out healthy cells.One user said the REGAL data was the “ultimate catalyst.”<stembedurl>https://stocktwits.com/kay91667/message/645624253</stembedurl>Another user said that “REGAL Phase 3 remains event-driven and approaching its final trigger.”<stembedurl>https://stocktwits.com/G_Trade/message/645600596</stembedurl>According to an SEC filing last week, Anson Funds Management disclosed that it held a 4.9% stake in the company, prompting a user to call it a “very exciting time” for shareholders.<stembedurl>https://stocktwits.com/Az2fl2025/message/645612860</stembedurl><h2 class="st-heading-2">IMPACT-AML Partnership</h2>Last month, Sellas partnered with IMPACT-AML, a European initiative dedicated to advancing AML treatments, to conduct a multi-site European clinical study of SLS009, the company’s selective CDK9 inhibitor.The stock came under some selling pressure in January over dilution fears after the company <a href="https://stocktwits.com/news-articles/markets/equity/sellas-life-sciences-stock-falls-for-fourth-straight-session/cmU2FjBR4dH">said</a> it received about $26.5 million from the exercise of common stock warrants.Year-to-date, SLS shares have gained around 3%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-sw-ip-pkg-stocks-slump-today/cZRtU4BR4yp">Why Did SW, IP, PKG Stocks Slump Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

Sellas Life Sciences Draws Significant Retail Buzz As Traders Eye REGAL Phase 3 Catalyst – SLS Stock Soars 15%

According to Stocktwits data, message volume on the platform surrounding the stock increased nearly 170% over the past 24 hours.

SELLAS Life Sciences Group Target of Unusually Large Options Trading (NASDAQ:SLS)

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS - Get Free Report) saw unusually large options trading activity on Monday. Stock traders acquired 42,324 call options on the company. This is an increase...

Notable Thursday Option Activity: SLS, MDGL, ZG

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in SELLAS Life Sciences Group Inc (Symbol: SLS), where a total volume of 38,228...

SELLAS Life Sciences Group (NASDAQ:SLS) Shares Up 9.8% - Here's Why

SELLAS Life Sciences Group (NASDAQ:SLS) Trading Up 9.8% - Here's What Happened...

SELLAS Life Sciences Group (NASDAQ:SLS) Shares Gap Down - Should You Sell?

SELLAS Life Sciences Group (NASDAQ:SLS) Shares Gap Down - Here's Why...

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Short Interest Down 14.9% in January

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS - Get Free Report) saw a significant decline in short interest in January. As of January 15th, there was short interest totaling 42,044,430 shares, a...

SELLAS Life Sciences Group (NASDAQ:SLS) Shares Down 7.4% - Should You Sell?

SELLAS Life Sciences Group (NASDAQ:SLS) Trading Down 7.4% - Here's What Happened...

SELLAS Life Sciences Group (NASDAQ:SLS) Trading 9.2% Higher - Still a Buy?

SELLAS Life Sciences Group (NASDAQ:SLS) Shares Up 9.2% - Here's Why...

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Software / SaaS

Cybersecurity

Cloud Infrastructure

AI / Semiconductors

Which beaten-down sector are you buying first?

Stocktwits

Stocktwits Polls

Traders are eagerly anticipating an imminent acquisition, particularly before the REGAL trial results, with AbbVie or Merck often speculated as potential buyers to secure next-gen oncology assets.

Bullish investors are reveling in rising share prices, asserting that heavy short interest, low short volume, and significant call option activity are signaling a massive short squeeze.

High anticipation surrounds the impending Phase 3 REGAL trial results for GPS in AML, with many believing a positive readout will lead to a revolutionary cancer treatment.

Investors foresee "generational wealth" with ambitious price targets, often ranging from $50 to over $180 per share, based on the anticipated success of the AML treatment.

The stock has achieved new 52-week highs, with analysts pointing to bullish technical indicators like monthly SMA crossovers and robust buying volume indicating a significant trend reversal.

SLS
SELLAS Life Sciences Group Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SLS News

SLSSELLAS Life Sciences Group Inc